Copyright
©The Author(s) 2020.
World J Stem Cells. Feb 26, 2020; 12(2): 139-151
Published online Feb 26, 2020. doi: 10.4252/wjsc.v12.i2.139
Published online Feb 26, 2020. doi: 10.4252/wjsc.v12.i2.139
Figure 2 Comparison of serum C-peptide concentration and insulin concentration between undifferentiated human Wharton's jelly mesenchymal stem cells and insulin-producing cells in response to glucose stimulation.
Differentiated insulin-producing cells (IPCs) secreted significant amounts of C-peptide and insulin, whereas undifferentiated human Wharton's jelly mesenchymal stem cells (MSCs) secreted lower amounts. aP < 0.05 when comparing the concentration of C-peptide and insulin by differentiated insulin-producing cells in response to the higher glucose (HG) and lower glucose (LG) environments.
- Citation: Hsiao CY, Chen TH, Huang BS, Chen PH, Su CH, Shyu JF, Tsai PJ. Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes. World J Stem Cells 2020; 12(2): 139-151
- URL: https://www.wjgnet.com/1948-0210/full/v12/i2/139.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i2.139